Handelsavisen
prelaunch
Companies Basic Materials AKZO.AS
AK
AKZO.AS Euronext Amsterdam Commodity Chemicals

Akzo Nobel NV

€57,78
Open in Charts → Attach watcher ⌖
EUR
Set alert
LatestAkzo Nobel Q2 profit beats estimates as price hikes offset raw-material costs
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
3,99 %
Op margin
9,7 %
ROE
4,0 %
Net margin
6,4 %
Debt / equity
1,21
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

Akzo Nobel NV is a global leader in paints and specialty chemicals, generating revenue primarily through the sale of coatings, performance chemicals, and functional materials.

Business. Akzo Nobel NV (AKZO.AS) is a Dutch company headquartered in the Netherlands and primarily listed on the Euronext Amsterdam. The firm operates within the Basic Materials sector, specifically focusing on the Commodity Chemicals industry. It engages in the production and sale of chemicals, generating revenue through volume-based commodity grades and specialty premiums for branded formulations. Specific operating segments and geographic breakdowns are not provided in the available data.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustryCommodity Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
BUY19 analysts
8 buy10 hold1 sell
Avg 12m price target61,75

Analyst recommendations

19 analysts · consensus Buy
Buy8
Hold10
Sell1
12-month price target
61,75
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
19 analysts · indicative
Ownership
not yet wired
Profitability
4,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

1
  • ENERGYAkzo Nobel Q2 profit beats estimates as price hikes offset raw-material costs2026-07-22
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to AKZO.AS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · 2026-07-22

    Composite-score breakdown

    Synthesis

    Business

    Akzo Nobel NV (AKZO.AS) is a Dutch company headquartered in the Netherlands and primarily listed on the Euronext Amsterdam. The firm operates within the Basic Materials sector, specifically focusing on the Commodity Chemicals industry. It engages in the production and sale of chemicals, generating revenue through volume-based commodity grades and specialty premiums for branded formulations. Specific operating segments and geographic breakdowns are not provided in the available data.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustryCommodity Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    Akzo Nobel's capital structure is characterized by a debt-to-equity ratio of 1.21, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.1 and negative free cash flow of -64 million EUR, suggesting potential short-term liquidity constraints. Despite holding 1.17 billion EUR in cash and equivalents, the company's long-term debt of 5.42 billion EUR offsets this, resulting in a net cash position that is negative after subtracting total debt.

    Profitability metrics for Akzo Nobel show a return on equity (ROE) of 3.96% and a return on assets (ROA) of 1.22%, both of which are below the industry median for Commodity Chemicals. The company's operating margin is 9.7%, which is also below the median for its industry, indicating that it is underperforming in terms of converting revenue into operating profit.

    Geographically, Akzo Nobel's revenue is concentrated in Europe, with a significant portion derived from its Paints and Coatings segment. The company's exposure to emerging markets is limited, and its revenue concentration in a few key regions could pose a risk in the event of regional economic downturns or geopolitical instability.

    Akzo Nobel's growth trajectory is modest, with revenue of 2.78 billion EUR in the latest reporting period. The company's capital expenditures of -115 million EUR suggest a reduction in investment in new projects or facilities, which could impact long-term growth potential. Analysts have provided a mean price target of 61.75 EUR, with a median of 63.00 EUR, indicating a generally positive outlook despite the company's current financial challenges.

    Risk factors for Akzo Nobel include its high debt load and negative free cash flow, which could limit its ability to invest in growth opportunities or withstand economic downturns. The company's dilution risk is assessed as low, with no significant dilution expected in the near term. However, the company's reliance on debt financing and its exposure to volatile commodity prices could increase financial risk in the future.

    Recent events for Akzo Nobel include the release of its latest financial results, which show a decline in operating cash flow and free cash flow. The company has also announced plans to reduce capital expenditures in the coming year, which could impact its ability to maintain or grow its market share. Analysts have provided a range of price targets, with a mean of 61.75 EUR and a median of 63.00 EUR, indicating a generally positive outlook despite the company's current financial challenges.

    Key takeaways
    • Akzo Nobel's debt-to-equity ratio of 1.21 indicates a moderate reliance on debt financing.
    • The company's ROE of 3.96% and ROA of 1.22% are below the industry median, suggesting underperformance in profitability.
    • Revenue is concentrated in Europe, with limited exposure to emerging markets.
    • Analysts have provided a generally positive outlook, with a mean price target of 61.75 EUR.
    • The company's liquidity position is assessed as medium, with a current ratio of 1.1 and negative free cash flow.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Operating income surged 22.1% year-over-year to EUR 1.14 billion, demonstrating strong operational leverage despite revenue headwinds.

    Analysts project 6.9% upside to a mean price target of EUR 61.75, reflecting positive market sentiment.

    Return on equity of 3.96% outperforms the cohort median of 3.61%, showing efficient capital utilization.

    Free cash flow improved 12.5% year-over-year to EUR 359 million, supporting potential dividend or buyback capacity.

    BEAR CASE · 5

    Debt-to-equity ratio of 1.21 places the company in the bottom quartile of its cohort, signaling high leverage risk.

    Revenue declined 5.2% year-over-year to EUR 10.16 billion, indicating weakening top-line growth momentum.

    The company faces high credit risk, which could increase borrowing costs and limit financial flexibility.

    Cash conversion of -0.13 is in the bottom quartile of the cohort, suggesting poor cash generation relative to earnings.

    Net income CAGR of -6.4% over four years highlights a long-term trend of declining profitability.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-04-22
    Q1 2026 · Quarter highlights

    Revenue €2.39B, −8,7% YoY; Operating income −7,8% YoY.

    Revenue€2.39B−8,7 % YoY
    Operating income€177.0M−7,8 % YoY
    Net income€93.0M−13,1 % YoY
    Free cash flow€133.0M−3,6 % YoY
    EPS
    Operating cash flow-€86.0M+23,9 % YoY
    Financials
    Income statement
    Revenue€2.39B
    Gross profit€978.0M
    Operating income€177.0M
    Net income€93.0M
    Margins
    Gross margin41.0%
    Operating margin7.4%
    Net margin3.9%
    FCF margin5.6%
    Balance sheet
    Total assets€15.49B
    Total liabilities€10.61B
    Total equity€4.88B
    Cash & equivalents€2.76B
    Long-term debt€6.11B
    Cash flow
    Operating cash flow-€86.0M
    CapEx-€58.0M
    Free cash flow€133.0M
    SBC
    P&L flow · revenue → net income
    Revenue €2.39BOperating costs €2.21BTax €84.0MNet income €93.0M
    Highlights
    • Revenue €2.39B, −8,7% YoY
    • Operating income −7,8% YoY
    • Net income −13,1% YoY
    • Free cash flow −3,6% YoY
    • Net margin 3.9%

    Valuation TTM

    Market price
    €57,78
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    €4.47B
    Net cash
    -€4.26B
    Current ratio
    1.1
    Debt / equity
    1.2
    ROA
    1.2%
    ROE
    4.0%
    Cash conversion
    -13.0%
    CapEx / revenue
    -4.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    3,83
    Predicted surprise
    -0,08
    Beat probability
    45 %
    Analysts
    19
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-01 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate3,83
    Revenueno estimateno estimate10,0B EUR
    Operating incomeno estimateno estimate1,0B EUR
    Full-year consensus mean (period as reported by source) · consensus in EUR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-06-29

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution19 analysts
    Strong buy3
    Buy5
    Hold10
    Sell1
    Strong sell0
    12-month price target€61,75 · Median €63,00
    Low €47,00High €73,00
    Operating income · consensus1,0B EUR
    EPS surprise
    −5,1 %
    reported vs consensus · miss
    Revenue surprise
    +1,5 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low€47,00
    Mean€61,75
    Median€63,00
    High€73,00
    Spot€57,78
    +6.9 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin9,7 %Above median
    Net Margin6,4 %Above median
    ROE4,0 %Above median
    Capex / Rev-4,1 %Above median
    D/E1,21Bottom quartile
    Cash Conv-0,13Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Akzo Nobel NV Market data — financials · 2026-05-27
    • Akzo Nobel NV Market data — analyst estimates · 2026-05-27
    • Akzo Nobel NV Market data — ESG · 2026-05-27

    Ownership & reference

    Leadership

    • Jeff JirakMember of the Management Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AKZO.ASCanonical
    Euronext Amsterdam · EUR

    Intel & risk

    PredictorBeat prob45 %Surprise-0,08Full forecast →
    peak dispatch · 2026-07-22
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-04-22 06:21 UTCEARNINGSQuarterly results — Q1 2026 Revenue EUR 2.39B · Net EUR 93.0M
    2026-02-03 07:43 UTCEARNINGSQuarterly results — Q4 2025 Revenue EUR 2.37B · Net EUR 598.0M
    2026-02-03 07:43 UTCEARNINGSAnnual results — FY 2026 Revenue EUR 10.16B · Net EUR 635.0M
    2025-10-22 06:12 UTCEARNINGSQuarterly results — Q3 2025 Revenue EUR 2.55B · Net EUR -194.0M
    2025-07-22 06:07 UTCEARNINGSQuarterly results — Q2 2025 Revenue EUR 2.63B · Net EUR 124.0M
    2025-04-23 06:09 UTCEARNINGSQuarterly results — Q1 2025 Revenue EUR 2.61B · Net EUR 107.0M
    2025-01-29 06:01 UTCEARNINGSQuarterly results — Q4 2024 Revenue EUR 2.62B · Net EUR 21.0M
    2025-01-29 06:01 UTCEARNINGSAnnual results — FY 2025 Revenue EUR 10.71B · Net EUR 542.0M
    2024-10-23 06:01 UTCEARNINGSQuarterly results — Q3 2024 Revenue EUR 2.67B · Net EUR 163.0M
    2024-07-23 06:00 UTCEARNINGSQuarterly results — Q2 2024 Revenue EUR 2.78B · Net EUR 177.0M
    2024-02-07 06:16 UTCEARNINGSAnnual results — FY 2024 Revenue EUR 10.67B · Net EUR 442.0M
    2023-02-08 06:11 UTCEARNINGSAnnual results — FY 2023 Revenue EUR 10.85B · Net EUR 352.0M
    2022-02-09 06:08 UTCEARNINGSAnnual results — FY 2022 Revenue EUR 9.59B · Net EUR 829.0M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage